Last edition
News about "Respiratory Drug"
Sino Biopharma and AstraZeneca Sign Licensing Deal for TQC3721
Sino Biopharmaceutical has signed an exclusive licensing agreement with AstraZeneca to develop, manufacture, and commercialise TQC3721, a novel PDE3/4 inhibitor for respiratory diseases.
Respiratory Drug | 09/07/2026 | By News Bureau
DFE Pharma Expands DPI Expertise at Hyderabad C2F Center to Boost Respiratory Drug Development
The C2F center supports global pharmaceutical companies to bring their products to market faster and more efficiently.
Respiratory Drug | 15/01/2025 | By Abha | 823
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy